Farm-level risk factors and treatment protocols for lameness in New Zealand dairy cattle.

AIMS: To identify farm-level risk factors for dairy cow lameness, and to describe lameness treatment protocols used on New Zealand dairy farms. METHODS: One hundred and nineteen farms from eight veterinary clinics within the major dairying regions of New Zealand were randomly enrolled into a cross-sectional lameness prevalence study. Each farmer completed a questionnaire on lameness risk factors and lameness treatment and management. Trained observers lameness scored cattle on two occasions, between October-December (spring, coinciding with peak lactation for most farms) and between January-March (summer, late lactation for most farms). A four-point (0-3) scoring system was used to assess lameness, with animals with a lameness score (LS) ≥2 defined as lame. At each visit, all lactating animals were scored including animals that had previously been identified lame by the farmer. Associations between the farmer-reported risk factors and lameness were determined using mixed logistic regression models in a Bayesian framework, with farm and score event as random effects. RESULTS: A lameness prevalence of 3.5% (2,113/59,631) was reported at the first LS event, and 3.3% (1,861/55,929) at the second LS event. There was a median prevalence of 2.8% (min 0, max 17.0%) from the 119 farms. Most farmers (90/117; 77%) relied on informal identification by farm staff to identify lame animals. On 65% (75/116) of farms, there was no external provider of lame cow treatments, with the farmer carrying out all lame cow treatments. Most farmers had no formal training (69/112; 62%). Animals from farms that used concrete stand-off pads during periods of inclement weather had 1.45 times the odds of lameness compared to animals on farms that did not use concrete stand-off pads (95% equal-tailed credible interval 1.07-1.88). Animals from farms that reported peak lameness incidence from January to June or all year-round, had 0.64 times odds of lameness compared to animals from farms that reported peak lameness incidence from July to December (95% equal-tailed credible interval 0.47-0.88). CONCLUSIONS: Lameness prevalence was low amongst the enrolled farms. Use of concrete stand-off pads and timing of peak lameness incidence were associated with odds of lameness. CLINICAL RELEVANCE: Veterinarians should be encouraging farmers to have formal lameness identification protocols and lameness management plans in place. There is ample opportunity to provide training to farmers for lame cow treatment. Management of cows on stand-off pads should consider the likely impact on lameness.

The prevalence of damaged tails in New Zealand dairy cattle.

AIMS: To undertake a survey of the prevalence of tail deviations, trauma and shortening on a representative selection of New Zealand dairy farms, and to assess whether sampling based on milking order could be used instead of random sampling across the herd to estimate prevalence. METHODS: This was a cross-sectional observational study, with 200 randomly selected farms enrolled across nine regions of New Zealand via selected veterinary practices (one/region). Veterinary clinics enrolled 20-25 farms each depending on region, with 1-2 trained technicians scoring per region. All cows (n = 92,348) present at a milking or pregnancy testing event were tail scored using a modified version of the New Zealand Veterinary Association Industry Scoring System. Palpated lesions were recorded as deviated (i.e. non-linear deformity), shortened (tail shorter than normal) or traumatic (all other lesions). The location of lesions was defined by dividing the tail into three equal zones: upper, middle and lower. A cow could have more than one lesion type and location, and/or multiple lesions of the same type, but for the prevalence calculation, only the presence or absence of a particular lesion was assessed. Prevalence of tail damage calculated using whole herd scoring was compared to random sampling across the herd and sampling from the front and back of the milking order. Bootstrap sampling with replacement was used to generate the sampling distributions across seven sample sizes ranging from 40-435 cows. RESULTS: When scoring all cows, the median prevalence for deviation was 9.5 (min 0.9, max 40.3)%; trauma 0.9 (min 0, max 10.7)%, and shortening was 4.5 (min 1.3, max 10.8)%. Deviation and trauma prevalence varied between regions; the median prevalence of deviations ranged from 6% in the West Coast to 13% in Waikato, and the median prevalence of all tail damage from 7% in the West Coast to 29% in Southland. Sampling based on milking order was less precise than random sampling across the herd. With the latter and using 157 cows, 95% of prevalence estimates were within 5% of the whole herd estimate, but sampling based on milking order needed > 300 cows to achieve the same precision. CONCLUSIONS AND CLINICAL RELEVANCE: The proportion of cows identified as having damaged tails was consistent with recent reports from New Zealand and Ireland, but at 11.5%, the proportion of cows with trauma or deviation is below acceptable standards. An industry-wide programme is needed to reduce the proportion of affected cows.

First report of the within-farm prevalence of bovine digital dermatitis in Chinese Holstein dairy cows in Jiangsu, China: A Bayesian modelling approach.

Digital dermatitis is one of the most important causes of lameness in dairy cattle, particularly in housed, intensively-managed cattle. The number of modern intensive dairy farms in China has increased markedly in recent years; however, we lack research on digital dermatitis in Chinese dairy cattle. This preliminary study aimed to estimate the prevalence of digital dermatitis on three conveniently selected farms in Jiangsu, China. The washed hind feet of all lactating cows on all three farms were examined during milking with the aid of a mobile phone light source. True prevalence was then estimated from the apparent prevalence using a Bayesian superpopulation approach to account for the imperfect nature of identifying digital dermatitis in cows during milking. Despite none of the farms having thought it necessary to implement routine digital dermatitis monitoring or control, the disease was found on all three sampled farms. All lesions observed were either chronic M4 or M4.1 type-lesions, with no M2 lesions (i.e. acute ulcerated lesions) observed. The estimated true prevalences on the farms were 7.3% (95% credible interval [CrI]: 5.4%-9.6%), 8.3% (95%CrI: 6.3%-10.8%), and 29.8% (95%CrI: 22.9%-37.2%).

Can lameness prevalence in dairy herds be predicted from farmers' reports of their motivation to control lameness and barriers to doing so? An observational study from New Zealand.

Understanding what motivates and prevents behavioral change in farmers is a critical step in disease control in dairy cattle. A total of 101 New Zealand dairy farmers across 8 regions were randomly enrolled into a cross-sectional study to investigate farmer barriers and motivators to lameness control for cows managed 100% at pasture and the relationship between these responses and the true lameness status on farm. Trained technicians lameness scored all lactating cows on the enrolled farms on 2 occasions during one lactation. Farm-level prevalence proportions were calculated as the mean of the 2 lameness scores. Enrolled farmers were asked their perception of lameness in the current milking season and responded to 26 ordinal Likert-type items with 5 options ranging from not important at all to extremely important. The questions were grouped under 3 categories; barriers to lameness control (n = 9), impacts of lameness (n = 10), and motivators to control lameness (n = 7). The association between farmer perception of lameness and lameness prevalence was reported using linear regression. Multiple-factor analysis was conducted to identify latent variable themes within the responses. Linear discriminant analysis was used to assess whether barriers, impacts, and motivators could be used to predict farmer perception of lameness and lameness prevalence. Lameness prevalence was 0.8% greater on farms where farmers perceived lameness as a moderate or a major problem compared with farms where the farmer perceived lameness as a minor problem or not a problem. Farmers ranked all potential motivators to lameness control as important and declared few barriers to be important at preventing them from controlling lameness. Feeling sorry for lame cows and pride in a healthy herd were the most important motivators, with lack of time and skilled labor the most important barriers. The most important effects of lameness were cow-related factors such as pain and production, with farm and industry impacts of less importance. Farmers place different weightings of importance on barriers to lameness control compared with motivators for lameness control. The impacts and motivators were strongly correlated with the first dimension from the multiple-factor analysis, with only weak correlation between barriers and the first dimension. Linear discriminant analysis identified that the importance that farmers place on barriers, motivators, and impacts of lameness were poor predictors of farmers' belief in regard to their lameness problem or actual lameness prevalence (above or below the median lameness prevalence for the study cohort). Despite relatively low lameness prevalence, many New Zealand dairy farmers believe lameness is a problem on their farm, and they rank welfare effects of lameness of high importance. To investigate how farmer behavior change can be used to manage lameness, future studies should consider theoretical social science frameworks beyond the theory of planned behavior or involve prospective interventional studies investigating farmer actions instead of beliefs.

The effect of parenteral vitamin B12 on the growth rate of dairy calves over the summer and autumn on seven farms from the Central Plateau, New Zealand.

AIMS: To investigate the effect of parenteral vitamin B12 supplementation on the growth rate of dairy heifer calves over the summer and autumn on seven farms from the Central Plateau of New Zealand, an area historically associated with low cobalt levels in grazing pasture. METHODS: This was a controlled clinical trial conducted on a convenience sample of seven farms with young female calves randomly assigned to three vitamin B12 treatment groups and followed through a grazing season. Two treatment groups received either monthly SC injections of a short-acting (SA) B12 formulation or 3-monthly injections of a long-acting (LA) B12 formulation and the third group received no treatment (NT). No additional parenteral vitamin B12 was given; however, all calves received additional cobalt (0.04-0.4 mg Co/kg liveweight) in the mineralised anthelmintic drenches given orally every month. Liveweight was recorded in December/January and at the end of the trial in May/June/July depending on farm. Pasture cobalt concentrations (mg/kg DM) were measured every month using 500-g herbage samples from 100-m transects in the area about to be grazed by the trial groups. RESULTS: There was evidence for a difference in growth rate between groups with mean final weight of 228 (95% CI = 212-243) kg for the LA groups, 224 (95% CI = 209-239) kg for the SA groups and 226 (95% CI = 211-241) kg for the NT groups respectively, (global p-value = 0.014). Calves given SA vitamin B12 were 3.77 (95% CI = 0.71-6.82) kg lighter than calves given LA vitamin B12 (p = 0.011). There was no evidence for a change in pasture cobalt concentrations (p = 0.32). CONCLUSIONS AND CLINICAL RELEVANCE: The results of this trial raise the question as to whether the routine use of vitamin B12 supplementation in young cattle from areas traditionally thought to be cobalt deficient is necessary, and further raise the possibility that vitamin B12 supplementation by repeated injection of SA products may negatively impact growth rates.

Prevalence of lameness on pasture-based New Zealand dairy farms: An observational study.

To understand the current impact of lameness on a system, it is important to define lameness prevalence across a range of dairy farms in that system. Prevalence estimates from dairy systems where cows are permanently managed at pasture are uncommon, although the limited data suggest that they have a lower lameness prevalence than housed cattle. One hundred and 20 farms from eight of the major dairying regions of New Zealand were randomly enrolled into a cross-sectional lameness prevalence study. On each of the farms, trained observers lameness scored cattle on two occasions, between October-December (spring, coinciding with peak lactation for most farms) and between January-March (summer, late lactation for most farms). At each visit, all lactating animals were scored using a four-point 0-3 scoring system, and included animals that had previously been identified as lame by the farmer. Animals with a lameness score (LS) ≥2 were defined as lame. Mixed logistic regression models assessed the interaction between region and season and island and season, respectively, and differences between the lameness prevalence within farm across the two seasons reported descriptively. A total of 116,317 locomotion scores over two events were conducted across the 120 farms. At the spring scoring event, 2128/60,007 (3.5 %) cows had a LS ≥2 and 1868/56,310 (3.3 %) cows had a LS ≥ 2 at the summer scoring event. At the farm level, across both scoring events, median lameness prevalence was 2.8 (interquartile range 1.5 - 4.5) %, with a range of 0.0-17.0 %. The median farm-level prevalence of LS = 3 was 0.5 % with a range of 0-4.6 %. The effect of timing of scoring was modified by region (p < 0.001), and island (p = 0.006) and at the individual farm level, differences between spring and summer farm level lameness prevalence were generally small (interquartile range: -1.8 to 1.0 %) but potentially large on individual farms (range from -12.3 % to 7.6 %). The median farm-level lameness prevalence estimate of 2.8 % across a random representative sample of New Zealand dairy farms give confidence that the overall prevalence of cattle lameness on New Zealand dairy farms is low. This adds to the growing evidence that pasture is a good management system with respect to hoof health. The evidence of strong seasonality of lameness was lacking. Instead of using lameness scoring to identify farms with large lameness problems, lameness scoring should be encouraged to farmers as a tool to improve the identification of lame animals.

Investigating the effect of prophylactic claw trimming on the interval between calving and first observed elevated locomotion score in pasture-based dairy cows.

AIMS: To evaluate, in a pasture-based dairy herd, the response to a three-time point hoof trimming regime on lameness incidence and time from calving to observation of an elevated locomotion score (LS). METHODS: This study was conducted on a 940-cow spring-calving herd in New Zealand's North Island between May 2018 and May 2019. Cows (n = 250) were randomly allocated to the hoof trimming group, with the remainder assigned to the non-trim cohort. One trained professional hoof trimmer used the five-step Dutch method to trim the hind feet of the trimming group. Throughout the subsequent production season, the whole herd was locomotion-scored fortnightly using the 4-point (0-3) Dairy NZ lameness score. Kaplan-Meier survival curves were used to assess the univariable effect of trimming on the interval between calving and first LS of ≥ 2 and first LS ≥ 1. A multivariable Cox proportional hazards regression was used to further evaluate the effect of trimming on time to elevated LS. RESULTS: Mean lameness (LS ≥ 2) prevalence was 2.6%, with 30% of cows having ≥ 4 observations during the study period when at least one LS was ≥ 2. For LS ≥ 1, mean prevalence was 40%, with 98.6% of cows having ≥ 4 observations during the study period when at least one LS was ≥ 1 during lactation. Hoof trimming had no apparent effect on the incidence of clinical lameness (LS ≥ 2) (trimmed vs. non-trimmed: 33.2% vs. 28.8%, respectively), but for LS ≥ 1, there was a small decrease in the incidence of LS ≥ 1 (trimmed vs. non-trimmed: 96.9% vs. 99.3%, respectively). The hazard of a cow having a first observed LS ≥ 2 in the control group was 0.87 (95% CI = 0.66-1.14) times that of the trimmed group; however, the hazard of a cow having a first LS ≥ 1 was 1.60 (95% CI = 1.37-1.88) times higher in the control than in the trimmed group. CONCLUSION AND CLINICAL RELEVANCE: On this farm, prophylactic hoof trimming had no clinically relevant impact on the incidence of clinical lameness and was not associated with clinically beneficial reductions in time to first observed LS ≥ 2. This may be because claw horn imbalance was not pronounced on this farm, with 53% of cows needing no trim on either hind limb on the first trimming occasion. Further research on the response to prophylactic trimming in pasture-based dairy cattle is required.

Investigating the use of local nerve blocks and general anaesthesia in reducing pain during and after disbudding procedure in goat kids.

The aim of this study was to compare the pain responses (as measured by noise and movement) during administration of local anaesthetic and during and after disbudding in goat kids. Eighty, seven- to ten-day-old, Saanen goat kids from one farm were enrolled and randomly assigned to one of four different methods of pain relief. Twenty kids had local anaesthetic (LA) applied at two sites per horn bud (LA group), 20 kids had LA applied to the two locations using a jet injector (JI group) and 20 kids were given a general anaesthetic (GA) using a combination of 0.02 mg/kg medetomidine and 2 mg/kg ketamine followed by a horn bud block applied as per the LA group (GA group). The remaining 20 kids had no treatment other than meloxicam (control group). Although responses between goat kids and at different time periods were variable, in comparison to the control group, GA eliminated the responses associated with injection of lignocaine and the responses during the period of disbudding, and provided a reduction in head scratches and shakes across multiple time periods.

Lameness recovery rates following treatment of dairy cattle with claw horn lameness in the Waikato region of New Zealand.

AIMS: To describe the time in days for lame dairy cows to recover after diagnosis and treatment of claw horn lameness, and to investigate whether cure rates differed between farms. METHODS: Five dairy farms in the Waikato region were conveniently enrolled into a descriptive epidemiological study. Three of these farms had dairy cattle enrolled over two consecutive seasons, while two farms enrolled for one year. Lame cattle diagnosed by the farmers were enrolled into the study if they had a lameness score (LS ≥ 2 on a 0-3 scale) and claw horn lesions. All enrolled animals were treated by a single veterinarian following a consistent methodology, and subsequently assessed for LS at a median frequency of 4 days from enrolment until they were sound (LS = 0). The times (days) taken for animals to become sound and non-lame (LS < 2) were reported for all animals, and Kaplan-Meier survival curves used to present the results. A Cox-proportional hazard model was used to assess if the hazard of soundness was associated with farm, age, breed, lesion, number of limbs involved, and LS at enrolment. RESULTS: A total of 241 lame cattle with claw horn lesions were enrolled across the five farms. White line disease was the predominant pain-causing lesion in 225 (93%) animals, and blocks were applied to 205 (85%) of enrolled animals. The overall median days from enrolment to becoming sound was 18 (95% CI = 14-21) days, and 7 (95% CI = 7-8) days to become non-lame. A difference in the hazards of lameness cure between farms was identified (p = 0.007), with median days to lameness cure between farms ranging from 11 to 21 days. No associations were identified between age, breed, limb, or LS at enrolment on the lameness cure rates. CONCLUSIONS: Treatment of claw horn lameness following industry-standard guidelines in dairy cattle on five New Zealand dairy farms resulted in rapid cure, although cure rates differed between farms. CLINICAL RELEVANCE: Following industry best-practice lameness treatment guidelines, including frequent use of blocks, can result in rapid lameness cure rates in New Zealand dairy cows. This study also suggests that management of lame cattle on pasture can positively benefit their welfare and recovery times. The reported cure rates provide veterinarians with benchmarks on the length of time after which a lame animal should be re-examined, and in the investigation of poor treatment response rates at the herd level.

Persistence of orthopaedic hoof blocks for the treatment of lame cattle kept permanently at pasture.

AIMS: To compare the retention by New Zealand dairy cows kept at pasture in a lame cow group, of three hoof block products commonly used in the remediation of lameness. METHODS: Sixty-seven farmer-presented Friesian and Friesian x Jersey dairy cows from a single herd in the Manawatu region (New Zealand) suffering from unilateral hind limb lameness attributable to a claw horn lesion (CHL) were randomly allocated to one of three treatments: foam block (FB), plastic shoe (PS) and a standard wooden block (WB). Blocks were applied to the contralateral healthy claw and checked daily by the farm staff (present/not present) and date of loss was recorded. Blocks were reassessed on Day 14 and Day 28 and then removed unless further elevation was indicated. Daily walking distances were calculated using a farm map and measurement software. Statistical analyses included a linear marginal model for distance walked until block loss and a Cox regression model for the relative hazard of a block being lost. RESULTS: Random allocation meant that differences between products in proportion used on left or right hind foot or lateral or medial claw were small. Mean distance walked/cow/day on farm tracks whilst the block was present was 0.32 (min 0.12, max 0.45) km/day; no biologically important difference between products in the mean distance walked was identified. Compared to PS, cows in the WB group were five times more likely to lose the block (HR = 4.8 (95% CI = 1.8-12.4)), while cows in the FB group were 9.5 times more likely to lose the block (HR = 9.5 (95% CI = 3.6-24.4)). CONCLUSIONS: In this study, PS were retained for much longer than either FB or WB. As cows were managed in a lame cow group for the study duration, walking distances were low and did not impact on the risk of block loss. More data are needed to define ideal block retention time. CLINICAL RELEVANCE: In cows with CHL the choice of block could be based on the type of lesion present and the expected re-epithelisation times.

Assessing Extensive Cow-Calf Welfare in Namibia: Feasibility of Adapting a New Zealand Beef Cow Welfare Assessment Protocol.

Namibia needs a robust welfare assessment protocol for beef cattle for benchmarking and trade. As there is presently no such protocol, one was developed for Namibian conditions based on one designed for extensive beef cattle in New Zealand which had been derived from the Welfare Quality and UC Davis Cow-Calf protocols, the modified protocol was evaluated in a semi-commercial farming village during the pregnancy testing of 141 cows from 5 herds of different households. Animal- and stockperson-based measures were assessed directly, cows were observed at grazing, and a questionnaire-guided interview was conducted. The protocol provided a good basis for welfare assessment, but additional measures and modifications were needed for the Namibian system. These were the effects of recurrent drought, predation, plant poisoning, external parasites, walking long distances to water and grazing, compulsory hot-iron branding, extraneous cattle marking, and variable standards of handling facilities. The protocol was modified to incorporate these changes, resulting in a total of 40 measures. It now needs full validation through widespread testing across the range of beef production systems used in Namibia.

Lesions found at foot trimming of dairy goats: Baseline data for comparing lesions and locomotion scoring.

Data on the foot lesions of housed dairy goats, especially those that are not lame, is sparse. In this study, visits were made to four farms for whole herd locomotion scoring after milking and to observe routine foot trimming. During trimming, the amount of trimming required for each hoof was recorded, alongside the presence of lesions. The process was repeated at the next routine foot trim on three of the four farms (on Farm 1 whole herd locomotion scoring after milking was not feasible). Across both visits, 3445 locomotion scores were recorded, alongside 3850 trimming and lesion records. There were large differences between farms and visits in the proportion of lame goats (6.7 to 25.5%) and in the proportion of goats which needed a substantial trim of all four feet (15.1-33.1%). Hoof lesions were observed in 65.5% of trimmed goats. We defined lesions by their site and presence of separation and/or granuloma, with white line separation being the most commonly recorded lesion (41.5% of goats). On all visits on the three farms which were locomotion scored, the number of goats recorded as lame was lower than the number observed with white line lesions, but the relative proportion ranged from 17% to 95.4%. Separations were much more common than granulomas, as granulomas were usually accompanied by separation. Toe lesions were much more likely to be associated with granulomas than white line lesions, with 91.5% of toe separations having granulomas but only 10.6% of white line separations. This study provides useful baseline data for comparing lesions and locomotion scoring between goat herds but also identifies areas where we need more data and more consensus.

Comparison of Three Anaesthetic Options to Reduce Acute Pain Response in Kid Goats.

Three options for anesthetizing the skin around the horn bud of dairy goat kids were explored. Forty-five <10-day-old Saanen goat kids from were randomly split into five treatment groups (topical anesthetic cream (TA), vapocoolant spray (VS), local anesthetic applied by jet injector (JI), control - no treatment but painful stimulus applied (C), sham - no treatment and touching sites with a finger. The painful stimulus was multiple needle pricks on the skin around the horn bud. The outcome variables measured were heart rate movement, and vocalization during treatment application and administration of a painful stimulus around the horn bud. Heart rates were greater during application of a VS compared to TA.Neither the TA nor the VS appeared to have any effect on the response to the painful stimulus. Kids in the JI group had a 96% reduced odds of expressing a marked pain response in comparison to TA group and an 83% reduction in the odds of a high movement grade during a painful procedure in comparison to the combined results of the other three treatment groups.

Graduate Student Literature Review: A systematic review on the associations between nonsteroidal anti-inflammatory drug use at the time of diagnosis and treatment of claw horn lameness in dairy cattle and lameness scores, algometer readings, and lying times.

The objectives of this systematic review were to investigate the association between nonsteroidal anti-inflammatory drug (NSAID) use during the treatment of claw horn lameness in dairy cattle and locomotion score (LS), nociceptive threshold, and lying times. A total of 229 studies were initially identified and had their title and abstract screened. From this, we screened the full text of 23 articles, identifying 6 articles for inclusion in the systematic review. Of these 6, 5 reported LS, 2 reported nociceptor thresholds, and 1 reported lying times. The quality of evidence was assessed using a Cochrane risk-of-bias tool and CONSORT items reported for each included study. Due to heterogeneity between the studies, data were reported following Cochrane's Synthesis without meta-analysis guidelines. Identified heterogeneity between the studies included differences in LS systems and statistical analyses, length of time from enrollment to outcome reported, the NSAID used, concomitant treatments administered, and severity and chronicity of lameness. Recommendations are made with respect to consistency of LS reporting and analysis, along with improvements that may be noted with compulsory reporting guidelines. There were at least some concerns over the risk of bias in 4 of the studies, with risks of bias present in missing outcome data between the study groups. Within the 5 studies included with LS outcomes, there were 22 different pairwise comparisons with either NSAID or NSAID + block as the intervention, with measures of association with presence or absence of lameness as the outcome available for 20 of these comparisons. Animals in the NSAID intervention groups had a lower point estimate lameness risk than animals in the comparison groups in 3 of 8 and 9 of 14 analyses for LS outcomes <10 and ≥10 d post-treatment, respectively. However, there was no difference identified between animals in the NSAID intervention groups compared with the animals in the control group in any of these pairwise comparisons with lameness as the outcome. Twelve pairwise comparisons were reported in the 2 studies with nociceptor threshold as an outcome. Animals in the NSAID intervention groups had a greater nociceptor threshold point estimate compared with animals in the comparison groups in 6 of 6 and 1 of 6 analyses for outcomes <10 and ≥10 d post-treatment, respectively. However, no differences were identified between animals in the NSAID intervention groups and those in the comparison groups. All 4 pairwise comparisons reported in the study with lying times as an outcome found no differences between animals in the NSAID groups and those in the comparison groups. Despite the widespread use of NSAID in the treatment of claw horn lameness, there is a lack of studies of NSAID association with LS, nociceptive thresholds, or lying times. The limited evidence is consistent with no association with NSAID use and those parameters, but comparability across studies was limited by heterogeneity.

Randomized clinical trial investigating the effect of exercise and standing on concrete prior to first calving on time to first lameness event in dairy heifers.

This controlled clinical trial investigated if an intervention immediately before the first calving event could reduce lameness incidence in pasture-based dairy heifers. Seven hundred ninety heifers across 6 farms in the Waikato region of New Zealand were randomly enrolled into treatment or control groups at a ratio of 1:1. The treatment consisted of heifers walking approximately 1 km from pasture along the farm race, standing on concrete for one hour, and then walking back to their paddock. This occurred once a day, 5 times a week, for 5 wk before calving. The control heifers were managed solely at pasture before calving. Just before calving, both groups were bought together and managed as one group for the remainder of the study. Heifers were followed for up to 28 wk, with fortnightly lameness scores collected to identify animals with a lameness score of ≥2 (lameness score 0-3). Lameness could also be diagnosed by the farmers, who had no formal lameness scoring training. The primary outcome of interest was time to first lame event. Secondary outcomes included milk solid production, change in body condition score during early lactation, time from onset of breeding season until conception, feasibility of the regimen and change in sole soft tissue thickness and profile. From a total of 782 heifers that had data collected on the outcomes, 102 (13.0%) individual first lameness events were recorded, 53 in heifers in the treatment group and 49 in control heifers. Of those 102 lameness events, 51 were first diagnosed by farmers. No apparent differences were detected in the hazard rate for time to first lame event between heifers in the 2 treatment groups. Treatment heifers had a 1.12 times hazard rate (95% confidence interval: 0.65-1.95) of a lame event compared with control heifers. No associations were identified between heifers in the 2 groups for any of the secondary outcome measures. However, farmers did report that the intervention was practical and easy to implement. It is possible that the intervention did not challenge the hoof enough, and that longer duration and distances walked may have resulted in a different outcome. Although no improvement in lameness outcomes were reported, no negative effects during and after the intervention were noted in animals in the intervention group. Further research into the area of lameness prevention is needed as there are few evidence-based solutions available to reduce lameness incidence in pasture-based systems.

The effect of pre-calving injection of trace mineral supplements on periparturient disease incidence in pasture based dairy cows.

Trace minerals, have a role in immune function and a trace mineral supplement (TMS) can improve animal health in dairy herds. This prospective randomised clinical study assessed whether subcutaneous injection of 5.5 mL of TMS (40 mg zinc, 10 mg manganese, 5 mg selenium, 15 mg copper per mL), 14-28 days before planned start of calving (PSC) reduced clinical mastitis (CM), subclinical mastitis (SCM) and purulent vaginal discharge (PVD). From four farms, half of 1700 cows stratified on somatic cell count, age and breed were randomly allocated to treatment or no treatment. Occurrence of CM from - 7 to PSC + 100 days, SCM at PSC + 60 days and PVD at PSC + 24 days was analysed using survival analysis and Bayesian generalised mixed multivariable models. From -7 to PSC +30 days, TMS reduced the adjusted hazard ratio (HR) for CM at quarter and cow level (P < 0.001), with no evidence for an effect beyond 30 days. The adjusted OR (and 95% highest density interval, HDI) for the effect of TMS on CM from -7 to PSC +30 days was 0.40 (95% HDI, 0.26-0.63) at quarter level, 0.51 (95% HDI, 0.38-0.69) at cow level and for SCM, 0.72 (95% HDI, 0.54-0.95). The difference in CM incidence from TMS at the cow level was -2.0% (95% HDI, -3.4 to -1.1%) and -1.2% (95% HDI, -3.2 to - 0.6%) at quarter level. No clear effect was identified of TMS on cumulative incidence of PVD.

The transfer of passive immunity in calves born at pasture.

Calf and dam separation is an area of growing public interest, and timely separation is also a practical challenge for pastoral farmers to achieve for all calves. Very few studies have investigated the success of leaving calves with their dams in pastoral conditions, so this observational study assessed serum total protein (STP) in calves born at pasture and left to suckle from their dams for up to 24 h. It also investigated failure of transfer of passive immunity (FPT) once calves had been provided colostrum from the farmer and some factors that may contribute to the risk of FPT. Over 2 years, 8 farms (4 in the North Island, 4 in South Island of New Zealand) were involved in an observational study where cows and calves were observed for 24 h a day for 2 wk per farm. Observers recorded the time from birth to first suckling, number of suckling events, time of calf removal from the dam, and ambient temperature. Calves were blood sampled on arrival at housing, before receiving colostrum from the farmer (d 1), and again 2 d later (d 3) to test for STP concentration. On d 1, 689 calves had blood samples collected, at a median of 11.5 (interquartile range 5.6 to 19.2) hours postbirth. Of these, 283 calves [41.1%; 95% confidence interval (CI) 37.4 to 44.9%] had STP >52 g/L (proportion by farm ranged from 10 to 78%). On d 3, 680 blood samples were collected, of which 16.0% (95% CI 13.5 to 19.0) had FPT (STP ≤52 g/L) with proportion by farm ranging from 2.5 to 31.6%. The FPT risk at d 3 in calves that did not suckle before housing was 2.91 (95% CI 2.04 to 4.13) times the risk in calves that suckled. For every hour longer postbirth that it took for a calf to have its first suckling event, odds of FPT at d 3 increased by 1.21 (95% CI 1.08 to 1.36) times, and compared with calves that only suckled once, calves that suckled 2, 3-5, or >5 times had 0.42 (95% CI 0.15 to 0.99), 0.35 (95% CI 0.15 to 0.76), and 0.10 (95% CI 0.005 to 0.47) times the odds of FPT, respectively. For every 1-percentage-point increase in the Brix % of the colostrum, the odds of FPT decreased by 33% (95% CI 24- to 42). Calves that suckled in the paddock and were fed colostrum with ≥22% Brix had the highest STP, and lowest odds of FPT, of any suckling/Brix % combination. There was a trend for STP to be greater in calves that suckled in the paddock and fed <22% Brix compared with calves that did not suckle in the paddock and fed ≥22% Brix. However, the calves in the former group also tended to have a greater risk of FPT at d 3, and a greater STP variability. There were very large between-farm variabilities for rates of suckling, colostrum feeding, and FPT risk that urgently require further investigation for calves born at pasture.

Suckling behavior of calves in seasonally calving pasture-based dairy systems, and possible environmental and management factors affecting suckling behaviors.

In recent years, interest has been increasing in whether farmed animals are able to live a reasonably natural life, with one particular area of concern being calf-dam separation. The objectives of this study were to monitor the timing and frequency of suckling behavior of calves left on pasture to suckle their dams for up to 24 h (interquartile range 4.0-15.5 h) and to investigate possible risk factors that may contribute to any variability seen. Over 2 yr, a convenience sample of 8 farms (4 in the North Island, 4 in the South Island of New Zealand) were involved in an observational study where cows and calves were observed for 24 h a day over a 2-wk-long period per farm. During the observation period, farmers continued to remove calves at the same frequency they normally did (which ranged from once a day to 4 times a day). Cows (between 2 and 12 yr old) and calves were observed from a scissor lift in or beside the calving paddock. Cows had numbers written on them, and observers used binoculars and spotlights. Observers recorded the length of stage 2 labor, time of birth, standing, and first suckling, number of suckling events, time of calf removal from the dam, temperature where the cows were grazing, and size of the grazing area they were calving in. Dams were body condition scored before calving, and their age was extracted from farm records. A total of 697 calves were observed during the study. A total of 444 of 697 calves [63.7%; 95% confidence interval (CI) = 60.0-67.3%] suckled in the calving paddock (farm range 40.0% to 90.2%). Of the 444 calves that suckled in the calving paddock, 407 (58.4%; 95% CI 54.6-62.1%) suckled within the first 6 h after birth (farm range 33.0% to 83.6%). Individual risk factors associated with the hazard rate ratio (HR) for time to first suckling event were time to standing (calves who took more than 1.3 h to stand had a longer time from birth to first suckle) and age of the dam [compared with calves that were born from dams >7 years of age, calves born to dams that were 2-3 and 4-7 yr of age had a 1.49 (95% CI 1.07-2.06) and 1.19 (95% CI 0.89-1.60) HR, respectively, for time from birth to first suckle in the calving paddock]. Farm risk factors associated with the HR of suckling were frequency of calf collection [calves that were born on farms that collected calves once a day suckled earlier than calves on farms that removed calves more than once a day (HR 1.52; 95% CI 1.25-1.84)] and temperature [a minimum temperature of <10°C within 6 h of a calf being born was associated with a 0.69 (95% CI 0.53-0.89) hazard of suckling in the calving paddock]. We observed very large farm variability that urgently requires further investigation if pasture-based farms are ever to adopt a system where calves remain with their dams for longer than 24 h.

Retention of internal teat sealants over the dry period and their efficacy in reducing clinical and subclinical mastitis at calving.

Internal teat sealants (ITS) reduce the risk of new intramammary infections over the dry period by forming a physical barrier to pathogen ingress. As the first and last 2 wk of the dry period are high-risk periods for new infections, maintaining an effective barrier in this period is a key requirement. Few studies have systematically examined sealant retention and none have done so under New Zealand pastoral conditions, where cows frequently move to separate grazing for dry periods, typically 80 to 90 d long. This multi-herd study was a split-udder equivalence trial comparing 2 ITS formulations for retention and efficacy in preventing periparturient clinical and subclinical mastitis. Both ITS contained 65% (2.6 g) bismuth salts, which contribute to the barrier within the teat canal, emulsified in ≤1.4 g of mineral oil. However, one ITS additionally contained <10% amorphous silica. At dry-off, treatment was randomly allocated to diagonal teat-pairs within 409 cows on 4 farms. All cows met industry best practice criteria for ITS treatment alone. The study unit was quarter within cow and farm. Outcomes included clinical mastitis (CM) incidence for the last 7 d of the dry period and first 42 d of lactation, subclinical mastitis (SCM) incidence 96 h after calving, and quantity of residual after centrifuging 50 mL of colostrum collected from each quarter within 24 h of calving. Proportional outcomes were analyzed using Bayesian mixed models with a binomial distribution and logit link function, whereas the quantity of residual was analyzed using Bayesian finite mixture models and cluster bootstrapping. We set a region of probable equivalence (ROPE) of ±2.5% between proportions and ±0.2 g for residual weight. Records were available for 1,596 quarters (399 cows). We detected no meaningful difference in incidence of CM or SCM attributable to differences in sealant: the model predicted treatment differences of 0.00 with a 95% highest density interval (HDI) of ±1.00%. Across all cows and farms, the marginal difference in the percentage of quarters with CM was 0.11% (95% HDI: -2.11 to 2.49%), and for SCM 0.00 (95% HDI: -1.98 to 1.94%). Including the quantity of residual recovered at calving did not improve fit or predictive ability of the models predicting CM or SCM, and the coefficient spanned the null value. The distribution of the weight of material recovered at calving was multi-modal; for 25% of quarters, more residual was recovered than inserted. When the residual weight was less than or equal to the median residual weight (2.06 g; range: 0.19-6.03 g), there was a ≥90% probability that any treatment difference in residual was ≤0.2 g. When the residual weight was between the median and 75th percentile (4.40 g; 95% HDI: 4.00 to 4.75 g), there was no clear difference in residual between products. Above the 75th percentile, there was a 90% probability that the residual from quarters differed by product type (difference = 0.36 g, 90% HDI: 0.20 to 0.54 g). In conclusion, both products had equivalent efficacy for SCM and CM. As the quantity of residual increased, the difference in residual weight recovered increased but this may represent increases in debris rather than indicating a more effective barrier.

Quantification of zinc concentrations in serum, milk and faeces of dairy cattle as a measure of effective zinc supplementation for management of facial eczema.

AIMS: To investigate the relationship between Zn concentrations in serum and those in milk or faeces, and to assess the ability of the Zn concentrations in milk, serum and faeces to predict intake of ZnO in dairy cattle. METHOD: Seventy cows from one commercial farm in the Waikato region of New Zealand received one of seven dose rates (0, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5 g/100 kg bodyweight (BW)) of ZnO given by oral drench, every morning, for 7 consecutive days. Every afternoon, milk and blood samples were collected from all cows. Free-catch faecal samples were collected during the afternoon milking on 3 days throughout the trial.Linear mixed models were used to assess the relationship between the concentration of Zn in serum and that in milk, and in faeces, respectively, and the relationship between dose rate of ZnO and concentrations of Zn in serum, faeces and milk, respectively. Receiver operating characteristic curve analysis was used to determine the ability of the Zn concentration in serum, milk and faeces to predict that a cow had been treated with a dose of ZnO ≥2.5 g/100 kg, the industry-recommended dose rate needed to protect against facial eczema. RESULTS: A 1-µmol/L increase in Zn concentration in milk was associated with a 0.14 (95% CI = 0.11-0.17) µmol/L increase in Zn concentration in serum. Zn concentration in faeces was scaled by its SD; a 1 SD increase was associated with a 1.83 (95% CI = 0.54-3.12) µmol/L increase in zinc concentration in serum. Zn concentrations in serum and faeces increased with increasing dose rates of ZnO. No differences in Zn concentrations in milk were noted between animals dosed with 1.5-3.5 g ZnO/100 kg BW, inclusive. At the optimal threshold of Zn concentration in serum to predict protective ZnO intake (22 µmol/L), the sensitivity was 0.76 (95% CI = 0.69-0.82) and specificity 0.85 (95% CI = 0.80-0.89). For the concentration of Zn in faeces, the optimal threshold was 17.36 mmol/kg, with a corresponding sensitivity of 0.84 (95% CI = 0.84-0.85) and specificity of 0.85 (95% CI = 0.73-0.94). At the optimal threshold for the Zn concentration in milk (76.6 µmol/L), the sensitivity was lower than the other two sample types at 0.59 (95% CI = 0.52-0.67), but with a similar specificity of 0.84 (95% CI = 0.79-0.88). CONCLUSIONS AND CLINICAL RELEVANCE: The concentration of Zn in milk shows promise as an initial screening test to identify dairy farms that do not provide adequate zinc to provide protection against FE.